Pay in 4 interest-free payments of $6.25 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Preclinical studies demonstrated that AOD-9604 was generally safe after chronic oral application in rats and cynomolgus monkeys, with no genotoxic concerns identified
It has shown potential for supporting the management of chronic gastrointestinal conditions, such as inflammatory bowel diseases (IBD), including ulcerative colitis (UC)
The compound has more safety data than efficacy data, which is unusual for a research peptide
& Rohde, V
Athletic testing considerations AOD 9604 appears on the World Anti-Doping Agency (WADA) prohibited list
Simple protocols using one peptide suit individuals preferring straightforward approaches
US$ 26.60
US$ 28.58
US$ 21.12
US$ 21.93
